| scholarly article | Q13442814 |
| P50 | author | Harlan M. Krumholz | Q28211478 |
| Stephen S. Gottlieb | Q47161314 | ||
| Javed Butler | Q63107356 | ||
| Christopher M O'Connor | Q64689171 | ||
| Yongfei Wang | Q92303614 | ||
| William T Abraham | Q109591812 | ||
| Daniel E. Forman | Q110750638 | ||
| Michael W. Rich | Q110833392 | ||
| Barry M. Massie | Q114321736 | ||
| Evan Loh | Q117270226 | ||
| P2093 | author name string | James B Young | |
| Lynne Warner Stevenson | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| hospitalization | Q3140971 | ||
| P304 | page(s) | 61-67 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure | |
| P478 | volume | 43 |
| Q36917527 | A Comparison of Traditional and Novel Definitions (RIFLE, AKIN, and KDIGO) of Acute Kidney Injury for the Prediction of Outcomes in Acute Decompensated Heart Failure |
| Q34292920 | A patient with heart failure and worsening kidney function |
| Q53591921 | A prognostic index for risk stratification for acute heart failure and death in subjects with ischemic cardiomyopathy and cardiac defibrillator. |
| Q48823339 | A transient improvement in renal function occurs after ischemic stroke |
| Q43890259 | Absence of interaction of diabetes mellitus with chronic kidney disease on mortality in acute heart failure. |
| Q97591195 | Acceleration of kidney function decline after incident hospitalization with cardiovascular disease: the Stockholm CREAtinine Measurements (SCREAM) Project |
| Q42315360 | Acute Cardiorenal Syndrome Type 1 in Patients With Congestive Heart Failure Exacerbations Is Not an Indicator of Poor Outcome and Increased Mortality |
| Q36886257 | Acute Kidney Injury in Pediatric Heart Failure |
| Q34322180 | Acute and acute-on-chronic kidney injury of patients with decompensated heart failure: impact on outcomes |
| Q36947421 | Acute cardio-renal syndrome: progression from congestive heart failure to congestive kidney failure |
| Q37415740 | Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome |
| Q34643664 | Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide |
| Q88687661 | Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices |
| Q37744472 | Acute kidney injury in patients with decompensated heart failure |
| Q38180360 | Acute kidney injury-epidemiology, outcomes and economics |
| Q36266039 | Acutely decompensated congestive heart failure: new therapies for an old problem |
| Q35151913 | Adenosine and kidney function: potential implications in patients with heart failure |
| Q28253255 | Adenosine receptors and the kidney |
| Q48171811 | Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction. |
| Q40238903 | Advances in the treatment of acute decompensated heart failure in the elderly |
| Q91640579 | An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome |
| Q36547312 | Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists |
| Q47346790 | Apolipoprotein L1 Genetic Variants Are Associated with Chronic Kidney Disease but Not with Cardiovascular Disease in a Population Referred for Cardiac Catheterization |
| Q37578565 | Are scores useful in advanced heart failure? |
| Q47211129 | Assessing the influence of acute kidney injury on the mortality in patients with acute myocardial infarction: a clinical trail |
| Q34765857 | Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study |
| Q84711425 | Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention |
| Q31122131 | Association between human resources and risk of hospitalisation in end-stage renal disease outpatients receiving haemodialysis: a longitudinal cohort study using claim data during 2013-2014. |
| Q36463883 | Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction |
| Q35781002 | Association of persistent and transient worsening renal function with mortality risk, readmissions risk, length of stay, and costs in patients hospitalized with acute heart failure |
| Q33964843 | Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure |
| Q43288643 | Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). |
| Q37873812 | Can we prevent or treat renal dysfunction in acute heart failure? |
| Q36716456 | Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers |
| Q35055236 | Cardiac resynchronization therapy in the cardiorenal syndrome |
| Q37861106 | Cardio-renal syndrome |
| Q28067064 | Cardio-renal syndrome |
| Q33728260 | Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative |
| Q36415902 | Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network |
| Q37590475 | Cardiorenal syndrome in children with heart failure |
| Q36203074 | Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implications |
| Q37217357 | Cardiorenal syndrome in heart failure: a cardiologist's perspective |
| Q35592477 | Cardiorenal syndrome type 1: a defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors |
| Q42115299 | Cardiorenal syndrome: Resistant to diuretics, sensitive to ultraflitration |
| Q27023089 | Cardiorenal syndrome: a cardiologist's perspective of pathophysiology |
| Q38218395 | Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins |
| Q38108765 | Cardiorenal syndrome: pathophysiology and treatment. |
| Q86811462 | Cardiorenal syndrome: review of our current understanding |
| Q37696360 | Cardiorenal syndrome: still not a defined entity |
| Q37212372 | Cardiorenal syndrome: ultrafiltration therapy for heart failure--trials and tribulations |
| Q34538721 | Cardiorenal syndromes |
| Q34373061 | Cardiorenal syndromes: pathophysiology to prevention |
| Q36574433 | Cardiovascular Collapse Associated With Irreversible Cardiomyopathy, Chronic Renal Failure, and Hypertension During Routine Dental Care |
| Q37070025 | Carotid Intima-Media Thickness and Incident ESRD: The Atherosclerosis Risk in Communities (ARIC) Study |
| Q44055036 | Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences |
| Q57628798 | Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial |
| Q38155422 | Changes in renal function in congestive heart failure |
| Q34380235 | Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure. |
| Q38516856 | Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact? |
| Q35640406 | Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure. |
| Q39220435 | Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study. |
| Q45716458 | Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety |
| Q35622822 | Clinical features of cardio-renal syndrome in a cohort of consecutive patients admitted to an internal medicine ward |
| Q92205638 | Clinical impact of visceral-to-subcutaneous fat ratio in patients with acute aortic dissection |
| Q35081524 | Clinical prediction scores for type 1 cardiorenal syndrome derived and validated in chinese cohorts. |
| Q38125509 | Clinical utility of biomarkers in chronic kidney disease and chronic heart failure |
| Q37685199 | Combined therapy with melatonin and exendin-4 effectively attenuated the deterioration of renal function in rat cardiorenal syndrome |
| Q36551356 | Comorbid Heart Failure and Renal Impairment: Epidemiology and Management |
| Q37051258 | Comparison of renal predictors for in-hospital and postdischarge mortality after hospitalized heart failure |
| Q40775380 | Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure. |
| Q40945168 | Constipation prophylaxis reduces length of stay in elderly hospitalized heart failure patients with home laxative use. |
| Q36802561 | Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment |
| Q38009708 | Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure |
| Q37817025 | Current treatment in acute and chronic cardio-renal syndrome |
| Q48338108 | Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure. |
| Q57911486 | Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference |
| Q43857252 | Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment |
| Q37556084 | Development and Validation of a Risk Score for Prediction of Acute Kidney Injury in Patients With Acute Decompensated Heart Failure: A Prospective Cohort Study in China |
| Q37680530 | Diagnosis and management of acute heart failure |
| Q87276313 | Dialysis-requiring acute kidney injury increases risk of long-term malignancy: a population-based study |
| Q48316825 | Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure |
| Q61798288 | Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension |
| Q36724656 | Drug discovery for heart failure: a new era or the end of the pipeline? |
| Q39289569 | Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study |
| Q34079591 | Early adverse events as predictors of 1-year mortality during mechanical circulatory support |
| Q38490345 | Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. |
| Q89100810 | Echocardiographic predictors of change in renal function with intravenous diuresis for decompensated heart failure |
| Q89482968 | Effect of Loop Diuretics on the Fractional Excretion of Urea in Decompensated Heart Failure |
| Q30361766 | Effect of renal function on prognosis in chronic heart failure. |
| Q34372498 | Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure |
| Q28212766 | Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure |
| Q45110909 | Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure |
| Q40085514 | Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography |
| Q38149800 | Epidemiology and importance of renal dysfunction in heart failure patients |
| Q37698861 | Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference |
| Q39258545 | Evolving treatment strategies for management of cardiorenal syndrome |
| Q47893208 | Favorable effects of early tolvaptan administration in very elderly patients after repeat hospitalizations for acute decompensated heart failure |
| Q42410586 | Fractional excretion of sodium predicts worsening renal function in acute decompensated heart failure |
| Q43610045 | Functional response to cardiac resynchronization therapy in patients with renal dysfunction and subsequent long-term mortality. |
| Q90436829 | Heart failure and acute renal dysfunction in the cardiorenal syndrome |
| Q43278687 | Hemodynamics, diuretics, and nesiritide: a retrospective VMAC analysis. |
| Q36022858 | High Risk of Herpes Zoster among Patients with Advance Acute Kidney Injury--A Population-Based Study |
| Q38217112 | Hyperglycemia in acute heart failure: an opportunity to intervene? |
| Q42870341 | Impact of Worsening Renal Function During Hospital Admission on Resource Utilization in Patients With Heart Failure |
| Q35014837 | Impact of acute kidney injury on clinical outcomes after ST elevation acute myocardial infarction |
| Q43780975 | Impact of acute serum creatinine elevation in patients treated with nesiritide. |
| Q53519480 | Impact of decreased serum albumin levels on acute kidney injury in patients with acute decompensated heart failure: a potential association of atrial natriuretic peptide. |
| Q87644784 | Impact of onset time of acute kidney injury on outcomes in patients with acute decompensated heart failure |
| Q37921161 | Impact of systemic venous congestion in heart failure |
| Q34985401 | Impact of worsening renal function during the treatment of decompensated heart failure on changes in renal function during subsequent hospitalization |
| Q92108931 | Importance of sodium-glucose cotransporter 2 inhibitor use in diabetic patients with acute heart failure |
| Q33799478 | Importance of venous congestion for worsening of renal function in advanced decompensated heart failure |
| Q35020305 | Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome |
| Q82660589 | In search of improved therapies for acute heart failure |
| Q37347009 | Incorporating common biomarkers into the clinical management of heart failure |
| Q39800705 | Initiation or maintenance of beta-blocker therapy in patients hospitalized for acute heart failure |
| Q35927894 | Inotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a Middle-Eastern Country (1991-2013). |
| Q64093664 | Interactive and potentially independent roles of renin-angiotensin-aldosterone system blockade and the development of cardiorenal syndrome type 1 on in-hospital mortality among elderly patients admitted with acute decompensated congestive heart failu |
| Q89726296 | Intravenous administration of iPS-MSCSPIONs mobilized into CKD parenchyma and effectively preserved residual renal function in CKD rat |
| Q33566655 | Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial |
| Q60935054 | KSHF Guidelines for the Management of Acute Heart Failure: Part III. Specific Management of Acute Heart Failure According to the Etiology and Co-morbidity |
| Q26772195 | Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice |
| Q38478533 | Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection |
| Q38373349 | Kidney dysfunction and left ventricular assist device support: a comprehensive perioperative review |
| Q36756211 | Lack of concordance in defining worsening renal function by rise in creatinine vs rise in cystatin C |
| Q35987008 | Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure |
| Q36460470 | Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction |
| Q34570220 | Long-term effects and prognosis in acute heart failure treated with tolvaptan: the AVCMA trial |
| Q37123184 | Long-term prognosis of acute kidney injury after first acute stroke |
| Q37303149 | Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis |
| Q36895752 | Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients |
| Q37765876 | Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue. |
| Q37343008 | Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? |
| Q37033137 | Low albumin levels and high impedance ratio as risk factors for worsening kidney function during hospitalization of decompensated heart failure patients |
| Q37837657 | Management and monitoring of haemodynamic complications in acute heart failure. |
| Q40304351 | Management of acute decompensated heart failure: treatment, controversy, and future directions |
| Q37730653 | Management of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspective |
| Q36112960 | Management of diuretic-refractory, volume-overloaded patients with acutely decompensated heart failure |
| Q84242255 | Management of the cardiorenal syndrome in acute heart failure |
| Q27028203 | Management of the cardiorenal syndrome in decompensated heart failure |
| Q37590471 | Managing acute renal failure in patients with acute decompensated heart failure: the cardiorenal syndrome |
| Q51544991 | Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. |
| Q37604882 | Mechanisms of the cardiorenal syndromes |
| Q37923340 | Medical therapy for acute decompensated heart failure: what recent clinical trials have taught us about diuretics and vasodilators |
| Q37877721 | Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure. |
| Q49620885 | MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4. |
| Q89454326 | Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in mice |
| Q85219737 | Myocardial infarction worsens glomerular injury and microalbuminuria in rats with pre-existing renal impairment accompanied by the activation of ER stress and inflammation |
| Q48278857 | NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure |
| Q36947290 | Natriuretic peptides in chronic kidney disease |
| Q36723849 | Nesiritide: a reappraisal of efficacy and safety |
| Q36631245 | Nesiritide: trials and tribulations |
| Q34160755 | Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study |
| Q34857517 | Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward. |
| Q35048051 | New biomarkers of acute kidney injury and the cardio-renal syndrome |
| Q37531314 | Noncardiac comorbidities and acute heart failure patients. |
| Q37194692 | Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure |
| Q35081515 | One-year survival and renal function recovery of acute kidney injury patients with chronic heart failure |
| Q80968730 | Optimal use of diuretics in patients with heart failure |
| Q35151512 | Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. |
| Q26822738 | Organ-specific responses to circulatory disturbances in heart failure: new insights |
| Q45147818 | Outcomes of heart failure-related hospitalization in adults with congenital heart disease in the United States |
| Q36247487 | Palliative care for end-stage heart failure |
| Q37812022 | Pathogenesis and therapeutic implications of cardiorenal syndrome |
| Q38586834 | Pathophysiology and clinical evaluation of acute heart failure |
| Q38667232 | Pathophysiology of cardiorenal syndrome in patients with heart failure: Potential therapeutic targets. |
| Q40995976 | Patient and Facility Variation in Costs of VA Heart Failure Patients |
| Q36093457 | Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure |
| Q34512319 | Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival |
| Q90111024 | Precipitating Factors for Hospitalization with Heart Failure: Prevalence and Clinical Impact Observations from the Gulf CARE (Gulf aCute heArt failuRe rEgistry) |
| Q36746053 | Predictors of Recurrent AKI. |
| Q59103471 | Predictors of a Rapid Decline of Renal Function in Patients with Chronic Kidney Disease Referred to a Nephrology Outpatient Clinic: A Longitudinal Study |
| Q35788963 | Predictors of re-hospitalization in patients with chronic heart failure |
| Q36085790 | Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography |
| Q37389820 | Prevalence and Prognosis of Anemia in Dogs with Degenerative Mitral Valve Disease |
| Q34181036 | Prevalence and clinical features of patients with the cardiorenal syndrome admitted to an internal medicine ward |
| Q43552499 | Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). |
| Q35622817 | Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role? |
| Q45922547 | Prognosis in patients with congestive heart failure and subacute renal failure treated with hemodialysis. |
| Q41104212 | Prognostic Value of Urinary Neutrophil Gelatinase-Associated Lipocalin on the First Day of Admission for Adverse Events in Patients With Acute Decompensated Heart Failure |
| Q34149704 | Prognostic impact of renal dysfunction does not differ according to the clinical profiles of patients: insight from the acute decompensated heart failure syndromes (ATTEND) registry |
| Q34264037 | Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigations |
| Q82387816 | Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction |
| Q35640412 | Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction |
| Q88099715 | Prognostic significance of dilated inferior vena cava in advanced decompensated heart failure |
| Q37352407 | Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure |
| Q37254563 | Rational use of diuretics in acute decompensated heart failure |
| Q42910207 | Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial—Cardiac Resynchronization Therapy (MADIT-CRT) |
| Q34470304 | Relation of worsened renal function during hospitalization for heart failure to long-term outcomes and rehospitalization |
| Q50126545 | Relationship between blood urea nitrogen-to-creatinine ratio at hospital admission and long-term mortality in patients with acute decompensated heart failure |
| Q64113211 | Relationship of the ORBIT and HAS-BLED scores with Killip class 3-4 in patients with ST-segment elevation myocardial infarction |
| Q33698744 | Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial |
| Q39018761 | Renal Replacement Therapy in Patients with Heart and Kidney Failure |
| Q37850384 | Renal biomarkers of kidney injury in cardiorenal syndrome |
| Q52651166 | Renal denervation has blood pressure-independent protective effects on kidney and heart in a rat model of chronic kidney disease. |
| Q39428715 | Renal dysfunction in African patients with acute heart failure |
| Q51181204 | Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. |
| Q35566683 | Renal dysfunction in acute heart failure |
| Q37900203 | Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment |
| Q82414338 | Renal function and mortality following cardiac resynchronization therapy |
| Q37205117 | Renal function, serum sodium level, and outcomes in hospitalized systolic heart failure patients: An analysis of the COAST study |
| Q38383238 | Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin |
| Q39193458 | Renal sodium avidity in heart failure: from pathophysiology to treatment strategies |
| Q35842921 | Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation |
| Q42841490 | Revisiting the cardio-renal hypothesis: the pivotal role of the kidney in congestive heart failure |
| Q88683605 | Right Heart Failure-Unrecognized Cause of Cardiorenal Syndrome |
| Q36073217 | Right ventricular dysfunction as predictor of longer hospital stay in patients with acute decompensated heart failure: a prospective study in Indonesian population. |
| Q36720773 | Risk for acute renal failure in patients hospitalized for decompensated congestive heart failure |
| Q88210184 | Risk prediction in infective endocarditis by modified MELD-XI score |
| Q35043153 | Role of Pulsatile Hemodynamics in Acute Heart Failure: Implications for Type 1 Cardiorenal Syndrome |
| Q36947434 | Role of adenosine antagonism in the cardio-renal syndrome: pathophysiology and therapeutic potential |
| Q36247473 | Role of vasopressin antagonists in the management of acute decompensated heart failure |
| Q40119202 | Rolofylline (KW-3902): a new adenosine A1-receptor antagonist for acute congestive heart failure |
| Q37770452 | Rubbing salt into wounds: hypertonic saline to assist with volume removal in heart failure |
| Q33799444 | Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure |
| Q37461040 | Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6. |
| Q58125992 | Sonographic Venous Velocity Index Identifies Patients with Chronic Kidney Disease and Severe Diastolic Dysfunction |
| Q89827951 | Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view |
| Q41855668 | Systematic review of prognostic prediction models for acute kidney injury (AKI) in general hospital populations |
| Q89138366 | Tacrolimus has immunosuppressive effects on heavy/light chain pairs and free light chains in patients after heart transplantation: A relationship with infection |
| Q58692613 | Telocinobufagin, a Novel Cardiotonic Steroid, Promotes Renal Fibrosis via Na⁺/K⁺-ATPase Profibrotic Signaling Pathways |
| Q38694908 | The Basic Metabolic Profile in Heart Failure-Marker and Modifier |
| Q85118860 | The Conundrum of Worsening Renal Function and Optimal Volume Status in Patients with Acute Decompensated Heart Failure |
| Q47803380 | The Kidney in Critical Cardiac Disease: Proceedings From the 10th International Conference of the Pediatric Cardiac Intensive Care Society |
| Q38249914 | The acute cardiorenal syndrome type I: considerations on physiology, epidemiology, and therapy |
| Q38241109 | The acute cardiorenal syndrome: burden and mechanisms of disease |
| Q51125585 | The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome. |
| Q37956552 | The cardiorenal syndrome in heart failure: cardiac? renal? syndrome? |
| Q34495307 | The cardiorenal syndrome: a review |
| Q34340391 | The cardiorenal syndrome: making the connection |
| Q38012654 | The corticotropin releasing factor system in the kidney: perspectives for novel therapeutic intervention in nephrology |
| Q38072257 | The disconnect between phase II and phase III trials of drugs for heart failure |
| Q36713575 | The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction |
| Q57162977 | The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes |
| Q30223904 | The feasibility of a telephone coaching program on heart failure home management for family caregivers |
| Q34439098 | The growth of acute kidney injury: a rising tide or just closer attention to detail? |
| Q34821510 | The impact of chronic kidney disease on the annual prognosis in patients 80+ years old suffering from chronic heart failure |
| Q43190668 | The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failure |
| Q43298059 | The impact of transient and persistent acute kidney injury on long-term outcomes after acute myocardial infarction |
| Q27011043 | The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?' |
| Q89823080 | The mid-term effect of left ventricular assist devices on renal functions |
| Q38068778 | The relevance of congestion in the cardio-renal syndrome |
| Q34366134 | The risk for chronic kidney disease in patients with heart diseases: a 7-year follow-up in a cohort study in Taiwan |
| Q36110466 | The role of hospitalists in the management of acute decompensated heart failure |
| Q38795329 | Ultrafiltration Therapy for Heart Failure: Balancing Likely Benefits against Possible Risks |
| Q36247480 | Ultrafiltration in decompensated heart failure |
| Q36949209 | Ultrafiltration in decompensated heart failure with cardiorenal syndrome |
| Q30315923 | Urinary Proteolytic Activation of Renal Epithelial Na+ Channels in Chronic Heart Failure |
| Q37078758 | Urinary biomarkers for acute kidney injury: perspectives on translation. |
| Q44488081 | Urinary metabolomic analysis for the identification of renal injury in patients with acute heart failure. |
| Q48232219 | Urine neutrophil gelatinase-associated lipocalin levels predict acute kidney injury in acute decompensated heart failure patients |
| Q30878953 | Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry |
| Q36752115 | Vasopressin antagonists in the management of heart failure |
| Q37147606 | Vasopressin-receptor antagonists in heart failure |
| Q83517026 | What have we learned about loop diuretics in acute decompensated heart failure? The DOSE trial |
| Q49911745 | Worsening Renal Function in Acute Heart Failure Patients Undergoing Aggressive Diuresis is Not Associated with Tubular Injury |
| Q35114953 | Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure |
| Q64108208 | Worsening renal failure in patients with acute heart failure: the importance of cardiac biomarkers |
| Q34354535 | Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions |
| Q49499751 | Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure |
| Q43144877 | Worsening renal function in patients admitted with acute decompensated heart failure: incidence, risk factors and prognostic implications. |
| Q46750124 | Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. |
| Q41216371 | Worsening renal function in patients hospitalized with acute heart failure: risk factors and prognostic significances |
| Q36381074 | Worsening renal function is not associated with response to treatment in acute heart failure. |
Search more.